NantHealth Welcomes Scott Maratea as Chief Revenue Officer to Executive Team
NantHealth (NASDAQ-GS: NH) has appointed Scott Maratea as its new Chief Revenue Officer. With over 30 years of experience in healthcare technology, Maratea has a proven track record of exceeding revenue targets and growing client relationships with leading healthcare organizations. Previously, he served as CRO at Curve Health and Life Image, Inc., demonstrating success in sales, marketing, and business development.
In his new role, Maratea will lead NantHealth's sales and revenue generation efforts, focusing on driving growth and expanding the company's market presence. His appointment is expected to help NantHealth achieve its growth objectives and continue delivering innovative healthcare solutions.
NantHealth (NASDAQ-GS: NH) ha nominato Scott Maratea come nuovo Chief Revenue Officer. Con oltre 30 anni di esperienza nel settore della tecnologia sanitaria, Maratea ha una comprovata esperienza nel superare gli obiettivi di fatturato e nel sviluppo delle relazioni con i clienti con importanti organizzazioni sanitarie. In precedenza, ha ricoperto il ruolo di CRO in Curve Health e Life Image, Inc., dimostrando successi nelle vendite, nel marketing e nello sviluppo commerciale.
Nel suo nuovo ruolo, Maratea guiderà gli sforzi di vendita e generazione di fatturato di NantHealth, concentrandosi sull'impulso della crescita e sull'espansione della presenza di mercato dell'azienda. Ci si aspetta che la sua nomina aiuti NantHealth a raggiungere i suoi obiettivi di crescita e a continuare a fornire soluzioni sanitarie innovative.
NantHealth (NASDAQ-GS: NH) ha nombrado a Scott Maratea como su nuevo Director de Ingresos. Con más de 30 años de experiencia en tecnología de la salud, Maratea tiene un historial probado de superar las metas de ingresos y de desarrollar relaciones con los clientes con las principales organizaciones de salud. Anteriormente, se desempeñó como CRO en Curve Health y Life Image, Inc., demostrando éxito en ventas, marketing y desarrollo de negocios.
En su nuevo cargo, Maratea liderará los esfuerzos de ventas y generación de ingresos de NantHealth, centrándose en impulsar el crecimiento y expandir la presencia de la empresa en el mercado. Se espera que su nombramiento ayude a NantHealth a alcanzar sus objetivos de crecimiento y continuar ofreciendo soluciones de salud innovadoras.
NantHealth (NASDAQ-GS: NH)는 Scott Maratea를 새로운 수익 책임자로 임명했습니다. 30년 이상의 의료 기술 경험을 보유한 Maratea는 주요 의료 기관과의 수익 목표 초과 달성 및 고객 관계 확대에서 입증된 실적을 가지고 있습니다. 이전에는 Curve Health와 Life Image, Inc.에서 CRO로 재직하며 판매, 마케팅 및 사업 개발에서 성공을 거두었습니다.
새로운 역할에서 Maratea는 NantHealth의 판매 및 수익 창출 노력을 이끌며, 성장 촉진 및 회사의 시장 존재 확대에 집중할 것입니다. 그의 임명은 NantHealth가 성장 목표를 달성하고 혁신적인 의료 솔루션을 지속적으로 제공하는 데 도움이 될 것으로 예상됩니다.
NantHealth (NASDAQ-GS: NH) a nommé Scott Maratea en tant que nouveau Directeur des Revenus. Fort de plus de 30 ans d'expérience dans la technologie de la santé, Maratea a fait ses preuves en dépassement des objectifs de revenus et en développement de relations clients avec des organisations sanitaires de premier plan. Auparavant, il a été CRO chez Curve Health et Life Image, Inc., où il a connu du succès dans les ventes, le marketing et le développement commercial.
Dans son nouveau rôle, Maratea dirigera les efforts de vente et de génération de revenus de NantHealth, en se concentrant sur la croissance et l'expansion de la présence de l'entreprise sur le marché. On s'attend à ce que sa nomination aide NantHealth à atteindre ses objectifs de croissance et à continuer à fournir des solutions de santé novatrices.
NantHealth (NASDAQ-GS: NH) hat Scott Maratea zum neuen Chief Revenue Officer ernannt. Mit über 30 Jahren Erfahrung in der Gesundheitstechnologie hat Maratea nachweislich Umsatzziele übertroffen und Kundenbeziehungen zu führenden Gesundheitsorganisationen ausgebaut. Zuvor war er CRO bei Curve Health und Life Image, Inc. und hat Erfolge in den Bereichen Vertrieb, Marketing und Geschäftsentwicklung vorzuweisen.
In seiner neuen Rolle wird Maratea die Vertriebs- und Umsatzgenerierungsbemühungen von NantHealth leiten und sich darauf konzentrieren, das Wachstum voranzutreiben und die Marktpräsenz des Unternehmens zu erweitern. Man erwartet, dass seine Ernennung NantHealth helfen wird, die Wachstumsziele zu erreichen und weiterhin innovative Gesundheitslösungen anzubieten.
- Appointment of experienced Chief Revenue Officer with 30+ years in healthcare technology
- Scott Maratea's proven track record of exceeding revenue targets and growing client relationships
- Potential for improved sales and revenue generation strategies
- None.
Prior to joining NantHealth, Scott served as the Chief Revenue Officer at Curve Health, where he successfully led the company's sales, marketing and business development efforts. Prior to that, Scott was the Chief Revenue Officer of Life Image, Inc., helping to scale and lead that company to acquisition in 2022. His strategic vision and leadership have been instrumental in driving growth and expansion in the healthcare market.
Scott's extensive background includes senior leadership positions at several healthcare technology companies and payers, where he played a key role in developing and implementing successful growth strategies. His deep understanding of the healthcare industry, coupled with his strong sales acumen, make him a valuable addition to the NantHealth team.
In his new role as Chief Revenue Officer, Scott will be responsible for leading NantHealth's sales and revenue generation efforts, with a focus on driving growth and expanding the company's presence in the healthcare market. He will work closely with the executive team to develop and execute strategic initiatives that drive revenue and deliver value to customers.
“We are thrilled to welcome Scott to our leadership team as the Chief Revenue Officer,” said Haris Naseem, MD, CEO of NantHealth. “Scott's proven track record of driving revenue growth and his deep industry expertise make him the perfect fit for this role. We are confident that his leadership will help us achieve our growth objectives and continue to deliver innovative solutions to our customers.”
Scott holds a Bachelor of Science degree from the University of Massachusetts Amherst.
NantHealth, a member of the NantWorks ecosystem of companies, provides enterprise solutions that help businesses transform complex data into actionable insights. By offering efficient ways to move, interpret and visualize complex and highly sensitive information, NantHealth enables customers in healthcare, life sciences, logistics, telecommunications and other industries to automate, understand and act on data while keeping it secure and scalable. NantHealth’s product portfolio comprises the latest technology in payer-provider collaboration platforms for real-time coverage, decision support and data solutions that provide multi-data analysis, reporting and professional services offerings. For more information, visit nanthealth.com, follow us on Twitter, Facebook, LinkedIn and YouTube and subscribe to our blog.
Forward Looking Statements
This news release contains certain statements of a forward-looking nature relating to future events or future business performance. Forward-looking statements can be identified by the words “expects,” “anticipates,” “believes,” “intends,” “estimates,” “plans,” “will,” “outlook” and similar expressions. Forward-looking statements are based on management’s current plans, estimates, assumptions and projections, and speak only as of the date they are made. Risks and uncertainties include, but are not limited to, statements regarding the timing and effectiveness of the reverse stock split and the Company’s ability to maintain its listing on Nasdaq (including its ability to achieve or maintain the minimum bid price required by Nasdaq and to comply with other requirements for listing on Nasdaq). Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the Company’s current plans, objectives, beliefs, expectations, and assumptions and are subject to a number of risks and uncertainties and other influences, many of which the Company has no control over. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the price and volume fluctuations in trading of the Company’s Common Stock, the potential adverse effect of the reduced number of shares outstanding following the reverse stock split on the liquidity of the Company’s Common Stock, potentially adverse Nasdaq decisions related to the listing of the Company’s Common Stock on the Nasdaq Capital Market. The Company undertakes no obligation to update any forward-looking statement in light of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements as a result of the impact of a number of factors, many of which are discussed in more detail in our reports filed with the Securities and Exchange Commission.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240828668149/en/
Jen Hodson
NantWorks
562-397-3639
jen@nant.com
Source: NantHealth, Inc.
FAQ
Who is the new Chief Revenue Officer of NantHealth (NH)?
What is Scott Maratea's background before joining NantHealth (NH)?
What will be Scott Maratea's responsibilities at NantHealth (NH)?
How might Scott Maratea's appointment impact NantHealth's (NH) future growth?
